How many boxes of canafenib/encofenib should be taken in one course of treatment?

Encorafenib is a targeted drug that targets BRAF mutations and is mainly used to treat certain types of cancer, such as unresectable or metastatic melanoma, metastatic non-small cell lung cancer, and metastatic colorectal cancer. The recommended dosage and treatment schedule vary depending on the specific circumstances of different patients.

For patients with BRAF V600E or V600K mutation-positive unresectable or metastatic melanoma, the recommended dose of canafenib is 450 mg once daily. This is equivalent to six 75mg capsules. When combined with binimetinib, another anticancer drug, patients need to continue taking it until their disease progresses or unacceptable side effects occur. In this case, a box of 75mg*42 pills of canafenib can provide 7 days of treatment, and if you choose the specification of 75mg*168 pills, it is enough to support a month of treatment. Depending on the progression of the condition, patients may need multiple boxes of medications to maintain the course of treatment, which usually require evaluation and adjustment under the guidance of a doctor.

For patients with BRAF V600E mutation-positive metastatic colorectal cancer, the recommended dose of canafenib is 300 mg once daily, equivalent to four 75 mg capsules. In this setting, canafenib is often used in combination with cetuximab, again until disease progression or unacceptable toxicity occurs. For such patients, the specification of 75mg*42 capsules is also suitable for one week of treatment, while 75mg*168 capsules can meet the needs of a longer period of time.

To sum up, when taking canafenib, patients need to determine the appropriate dose and course of treatment based on their disease type and doctor’s recommendations. Patients may need a dose of six pills per week for melanoma, or four pills per day for colorectal cancer. Since drugs come in different specifications, patients need to discuss it with their doctor before starting treatment, and the availability of the drug should also be taken into consideration. Typically, the doctor will evaluate the effectiveness of the treatment during regular check-ups and decide whether the dose needs to be adjusted or the treatment plan needs to be changed based on the patient's response.